This study is looking at a potential new treatment of inflammatory disorders (e.g. Chronic fever syndromes,) and diseases of the nervous system (e.g. Alzheimer’s).

2 x 3 nights
2 visits

The medication is designed to treat these disorders by inhibiting the over-activation of the immune system. The purpose of this study is to investigate how this medication is absorbed and processed in a healthy body.

This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.

Call us on 1800 243 733 to discuss your eligibility today!

Eligibility

Biological Sex Healthy males (and females of non-childbearing potential)
Age 18 – 55 years old
BMI 18 – 32 kg/m²
Body Weight > 50kg
Medical History Nothing significant
Smoking History Non-smokers or social smokers (no more than 2 cigarettes per week)
Dietary Restrictions No relevant dietary restrictions (must be able to consume a high fat breakfast with milk, eggs, bacon and hash browns)